Cell Based Assay Market is Expected to Reach US$ 18.5 Bn by 2025Posted by Shristi on October 22nd, 2019 Analyst Speak: “The Global Cell Based Assay Market is expected to reach US$ 18.5 Bn by 2025 owing to growth in R&D for the development of newer techniques” The global cell based assay market is expected to reach US$ 18.5 Bn by 2025. The factors which are driving the growth of global cell based assay market are raising demand for biological drugs, upsurge in the frequency and incidence of chronic diseases such as cancer, technological advancements in the drug discovery process, escalating research and development, increasing awareness in the government about the toxicity screening in drugs, and upsurge in government funding for the products. Moreover, growth in the adoption of cell-based consumables by various organizations might propel the cell-based assay market over the coming years. The global cell based assay market is also driven by the numerous advantages this technique provides such as to determine the different parameters such as biochemical or cellular functions of a living cell, to measure motility, cell proliferation, toxicity, enzyme activity, and morphology in the diagnostics and drug discovery. They are also used in the research of new drugs by using functional cells as diagnostic tools. Cell based assay is approved in several therapeutic areas such as cancer, stem cells, immunology, and others. Still, deficiency of skilled professionals for conducting the cell based assays, the high cost of the instruments, and rigorous regulatory guidelines might obstruct the growth of cell based assay market. Global cell based assay market is segmented on the basis of product type, application, end user, and region. Avail Sample Report of the Market @ https://www.precisionbusinessinsights.com/request-sample?product_id=16684 ADME Studies Dominate the Global Cell Based Assay Market Based on the application, global cell based assay market is segmented into ADME studies, basic research, predictive toxicology, drug discovery, and other. ADME studies dominate the global cell based assay market because through this a drugs metabolism inside the body can be known and it also helps in the design and development of new drug products. An ADME study tells about the drugs absorption, distribution, metabolism, and excretion. North America Leads the Global Cell Based Assay Market PBI’s global cell based assay market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America dominated the global cell based assay market through 2014-2018 and expected to dominate over 2019-2025 owing to increase in prevalence of chronic diseases such as cancer for instance in 2016, there were an estimated 15.5 million cancer survivors in the United States (according to National Cancer Institute). Additionally, technological advancements, escalating funding from government, improved research and development facilities fuel the growth of cell based assay market in North American region. Europe cell based assay market estimated for a substantial share in global cell based assay market due to its increasing disposable income especially in country like UK, increasing research and development in the field of drug discovery, and growing occurrences of chronic diseases. According to World Health Organization Europe accounts for one quarter of the total global cancer cases. Asia Pacific cell based assay market is expected to grow significantly due to their developing economies, development of new techniques, increase in the prevalence of diseases, continuously growing population, development of healthcare infrastructure, and technological advancements. Development of newer assay techniques and strategic alliances are the key strategies adopted by market players Global cell based assay market further reveals that the key player’s increasingly adopting strategies such as development of newer techniques, mergers and collaborations to improve market revenue share and gaining significant geographic presence across the region.
Key player’s profiles in the report are PerkinElmer Inc. (USA), GE Healthcare (UK), ProQinase GmbH (Germany), Danaher Corporation (USA), Essen BioScience Inc. (USA), Lonza Group (USA), Thermo Fisher Scientific Inc. (USA), Abenex Capital SA (France), Axiogenesis AG (Germany), and Beckman Coulter (USA), Metrion Biosciences Ltd. (UK). For More Information @ https://www.precisionbusinessinsights.com/market-reports/global-cell-based-assay-market/ Precision Business Insights (PBI) in its report titled “Global Cell Based Assay Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Detailed Segmentation By Product Type
By Application
By End User
Geography North America
Europe
Asia-Pacific
Latin America
Middle East and Africa (MEA)
About Us: Like it? Share it! More by this author |